CONTINUUS Pharmaceuticals Raises $5 M in Series B Round, Led by Mark Bamforth Who Will Join the Board of Directors

Thursday, September 5th, 2019 - General News,Press Release

This round was led by Mark Bamforth, President & CEO at Arranta Bio, with participation by IMA Industria Macchine Automatiche and other investors from previous rounds. Bamforth will also join the Board of Directors of CONTINUUS, bringing decades of experience in commercial pharmaceutical manufacturing. Find the full press release here